Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-DOTATATE PET/CT and 123I-MIBG Scintigraphy Imaging of Neuroblastoma
NCT04559217Phase 2Recruiting
- Sponsor
- Centre de recherche du CHUS
- Start
- Dec 2021
- Primary completion
- Dec 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga 68 dotatate in neuroblastoma, sponsored by Centre de recherche du CHUS. Started Dec 2021; status: recruiting.
02
Drugs
gallium ga 68 dotatate
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT04559217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04559217.